GA-68 DOTATOC

About Ga-68 DOTATOC PET CT

Ga-68 DOTATOC PET CT is a specialized nuclear medicine imaging examination that uses a Gallium-68 labelled DOTATOC radiotracer to evaluate somatostatin receptor expression in tissues. It combines functional PET imaging with anatomical CT imaging to provide detailed information about tracer distribution and uptake.

Ga-68 DOTATOC PET CT is particularly useful in the evaluation and management of selected neuroendocrine tumors and other conditions where somatostatin receptor imaging is clinically indicated.

What Does Ga-68 DOTATOC PET CT Evaluate?

This examination evaluates the distribution and uptake of the Ga-68 DOTATOC radiotracer in areas expressing somatostatin receptors. It can help identify and characterize receptor-positive lesions throughout the body.

The scan may provide information about the location and extent of disease and can be correlated with clinical findings, laboratory results, pathology and other imaging studies.

Why Is Ga-68 DOTATOC PET CT Performed?

Doctors may recommend Ga-68 DOTATOC PET CT for selected patients with suspected or known neuroendocrine tumors when somatostatin receptor imaging is clinically required.

It may be used for disease localization, staging, assessment of disease extent, evaluation of suspected recurrence or follow-up when clinically appropriate. The exact indication is determined by the treating specialist.

How Is Ga-68 DOTATOC PET CT Performed?

The prescribed Ga-68 DOTATOC radiotracer is administered under the supervision of the nuclear medicine team. After an appropriate uptake period, PET and CT images are acquired using the PET CT scanner.

The patient needs to remain as still as possible during image acquisition. The nuclear medicine team provides instructions regarding tracer administration, positioning and scan timing.

The duration of the examination can vary depending on the prescribed protocol and imaging requirements.

Preparation for Ga-68 DOTATOC PET CT

Preparation requirements may vary according to the clinical indication and nuclear medicine protocol. Patients should follow the specific instructions provided by the nuclear medicine team before the examination.

Patients should inform the nuclear medicine team about current medications, pregnancy or possible pregnancy, breastfeeding, previous nuclear medicine procedures and other relevant medical conditions.

Patients should not stop or change prescribed medicines unless specifically instructed by their treating doctor or nuclear medicine team.

Benefits of Ga-68 DOTATOC PET CT

Ga-68 DOTATOC PET CT provides functional information about somatostatin receptor expression together with anatomical information from CT. This can help physicians identify receptor-positive lesions and assess their distribution within the body.

The examination can provide valuable information for diagnosis, staging and treatment planning in appropriate patients with neuroendocrine tumors.

Understanding the Ga-68 DOTATOC PET CT Report

The report may describe areas of increased or abnormal Ga-68 DOTATOC uptake and relevant anatomical findings seen on CT. The significance of tracer uptake depends on its location, intensity, clinical context and other imaging findings.

PET CT findings should be interpreted by a qualified nuclear medicine physician together with the patient's symptoms, medical history, pathology, laboratory results and other relevant investigations.

Ga-68 DOTATOC PET CT in Hyderabad

Focus Diagnostics provides advanced PET CT and nuclear medicine imaging services in Hyderabad for appropriate clinical indications. Patients can consult their referring physician or nuclear medicine team regarding preparation, appointment requirements and report interpretation.